BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30578940)

  • 1. Late Mortality after Allogeneic Bone Marrow Transplantation in Childhood for Bone Marrow Failure Syndromes and Severe Aplastic Anemia.
    Holmqvist AS; Chen Y; Wu J; Battles K; Francisco L; Hageman L; Kung M; Ness E; Parman M; Winther JF; Rosenthal J; Arora M; Armenian SH; Bhatia S
    Biol Blood Marrow Transplant; 2019 Apr; 25(4):749-755. PubMed ID: 30578940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in Childhood.
    Holmqvist AS; Chen Y; Wu J; Battles K; Bhatia R; Francisco L; Hageman L; Kung M; Ness E; Parman M; Salzman D; Wadhwa A; Winther JF; Rosenthal J; Forman SJ; Weisdorf DJ; Armenian SH; Arora M; Bhatia S
    JAMA Oncol; 2018 Dec; 4(12):e182453. PubMed ID: 30054602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late mortality after autologous blood or marrow transplantation in childhood: a Blood or Marrow Transplant Survivor Study-2 report.
    Holmqvist AS; Chen Y; Wu J; Battles K; Bhatia R; Francisco L; Hageman L; Kung M; Ness E; Parman M; Salzman D; Winther JF; Rosenthal J; Forman SJ; Weisdorf DJ; Arora M; Armenian SH; Bhatia S
    Blood; 2018 Jun; 131(24):2720-2729. PubMed ID: 29661789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the North American Pediatric Aplastic Anemia Consortium and the Pediatric Transplantation and Cellular Therapy Consortium.
    Pulsipher MA; Lehmann LE; Bertuch AA; Sasa G; Olson T; Nakano T; Gilio A; Burroughs LM; Lipton JM; Huang JN; Dickerson K; Bertaina A; Zhuang C; Malsch M; Fleming M; Weller E; Shimamura A; Williams DA
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28444. PubMed ID: 32776425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic Bone Marrow Transplants for Pediatric Severe Aplastic Anemia: Real-world Data comparing Matched Related and Unrelated Donors in a Developing Country. Retrospective study on behalf of the Pediatric Hematopoietic Stem Cell Transplant Working Group of the Brazilian Bone Marrow Transplantation Society (SBTMO) and the Brazil-Seattle Consortium (Gedeco).
    Darrigo LG; Colturato V; de Souza MP; Loth G; Calixto R; Seber A; Zecchin VG; Esteves Daudt L; Tavares RB; Arcuri L; de Macedo AV; Vieira AK; Kuwahara C; Ribeiro L; Fernandes JF; Flowers ME; Pasquini R; Bonfim C
    Pediatr Transplant; 2019 Nov; 23(7):e13552. PubMed ID: 31297928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 Decades: A Blood or Marrow Transplant Survivor Study Report.
    Bhatia S; Dai C; Landier W; Hageman L; Wu J; Schlichting E; Siler A; Funk E; Hicks J; Bosworth A; Te HS; Francisco L; Bhatia R; Salzman D; Goldman FD; Forman SJ; Weisdorf DJ; Wong FL; Arora M; Armenian SH
    JAMA Oncol; 2021 Nov; 7(11):1626-1634. PubMed ID: 34499078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation.
    Gillio AP; Boulad F; Small TN; Kernan NA; Reyes B; Childs BH; Brochstein JA; Laver J; Castro-Malaspina H; O'Reilly RJ
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):18-24. PubMed ID: 9209737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late mortality after bone marrow transplant for chronic myelogenous leukemia in the context of prior tyrosine kinase inhibitor exposure: A Blood or Marrow Transplant Survivor Study (BMTSS) report.
    Wu J; Chen Y; Hageman L; Francisco L; Ness EC; Parman M; Kung M; Watson JA; Weisdorf DJ; Snyder DS; McGlave PB; Forman SJ; Arora M; Armenian SH; Bhatia R; Bhatia S
    Cancer; 2019 Nov; 125(22):4033-4042. PubMed ID: 31412155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party.
    Bacigalupo A; Hows J; Gluckman E; Nissen C; Marsh J; Van Lint MT; Congiu M; De Planque MM; Ernst P; McCann S
    Br J Haematol; 1988 Oct; 70(2):177-82. PubMed ID: 3056497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late Mortality after Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A Report from the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2).
    Wadhwa A; Chen Y; Holmqvist A; Wu J; Ness E; Parman M; Kung M; Hageman L; Francisco L; Braunlin E; Miller W; Lund T; Armenian S; Arora M; Orchard P; Bhatia S
    Biol Blood Marrow Transplant; 2019 Feb; 25(2):328-334. PubMed ID: 30292746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
    Socié G; Stone JV; Wingard JR; Weisdorf D; Henslee-Downey PJ; Bredeson C; Cahn JY; Passweg JR; Rowlings PA; Schouten HC; Kolb HJ; Klein JP
    N Engl J Med; 1999 Jul; 341(1):14-21. PubMed ID: 10387937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic bone marrow transplantation for fourteen patients with severe aplastic anemia.
    Hsueh EJ; Hwang WS; Huang SH; Chao TY; Chang JY; Wang CC
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Apr; 57(4):247-53. PubMed ID: 8705875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late graft rejection and second infusion of bone marrow in children with aplastic anaemia.
    Eapen M; Davies SM; Ramsay NK
    Br J Haematol; 1999 Jan; 104(1):186-8. PubMed ID: 10027732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic bone marrow transplantation for severe aplastic anemia: the Vancouver experience.
    Cuthbert RJ; Shepherd JD; Nantel SH; Barnett MJ; Reece DE; Klingemann HG; Chan KW; Spinelli JJ; Sutherland HJ; Phillips GL
    Clin Invest Med; 1995 Apr; 18(2):122-30. PubMed ID: 7788957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial.
    Locatelli F; Bruno B; Zecca M; Van-Lint MT; McCann S; Arcese W; Dallorso S; Di Bartolomeo P; Fagioli F; Locasciulli A; Lawler M; Bacigalupo A
    Blood; 2000 Sep; 96(5):1690-7. PubMed ID: 10961865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.
    Bejanyan N; Kim S; Hebert KM; Kekre N; Abdel-Azim H; Ahmed I; Aljurf M; Badawy SM; Beitinjaneh A; Boelens JJ; Diaz MA; Dvorak CC; Gadalla S; Gajewski J; Gale RP; Ganguly S; Gennery AR; George B; Gergis U; Gómez-Almaguer D; Vicent MG; Hashem H; Kamble RT; Kasow KA; Lazarus HM; Mathews V; Orchard PJ; Pulsipher M; Ringden O; Schultz K; Teira P; Woolfrey AE; Saldaña BD; Savani B; Winiarski J; Yared J; Weisdorf DJ; Antin JH; Eapen M
    Blood Adv; 2019 Oct; 3(20):3123-3131. PubMed ID: 31648332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second bone marrow transplantation for severe aplastic anemia: analysis of 34 cases.
    de Medeiros CR; Bitencourt MA; Medeiros BC; Ioshizumi L; Pasquini R
    Bone Marrow Transplant; 2001 Nov; 28(10):941-4. PubMed ID: 11753548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second allogeneic bone marrow transplantation after myeloablative conditioning analysis of 43 cases from single institution.
    Al-Qurashi F; Ayas M; Al Sharif F; Ibrahim E; Sahovic E; Al Mahr M; Chaudhri N; Al Mohareb F; Al Zahrani H; Al Jefri A; Al Omar H; Al Shanqeeti A; Seth P; Aslam M; El Solh H; Aljurf M
    Hematology; 2004 Apr; 9(2):123-9. PubMed ID: 15203867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unrelated donor bone marrow transplantation for children and adolescents with aplastic anaemia or myelodysplasia.
    Davies SM; Wagner JE; Defor T; Blazar BR; Katsanis E; Kersey JH; Orchard PJ; McGlave PB; Weisdorf DJ; Ramsay NK
    Br J Haematol; 1997 Mar; 96(4):749-56. PubMed ID: 9074418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic bone marrow transplantation for severe aplastic anemia: the Hong Kong scenario.
    Au WY; Lie AK; Kwong YL; Chan TK; Chim CS; Lee CK; Chiu EK; Liang R
    Hematol Oncol; 1998 Jun; 16(2):41-6. PubMed ID: 10065111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.